DoW Bone Marrow Failure, Investigator-Initiated Research Award
Funds mature bone marrow failure research, including drug-development groundwork, but not a clinical trial itself.
Some bone marrow failure ideas have already cleared the earliest hurdle — there is real preliminary data behind them — and what they need next is the runway to become something closer to a treatment.
This award funds that next stage: studies that further develop a mature idea, expand on a key discovery, and could meaningfully advance bone marrow failure research or patient care. That includes tra…
Mature bone marrow failure research building on an existing discovery, including translational and clinical research and Investigational New Drug-enabling work such as lead compound characterization and toxicology, with preliminary data required and clinical trials themselves excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up